Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna, Georg C Hutterer · 2024
Read Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies by Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna, Georg C Hutterer (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11675435.txt.
Description
Valentina Schiavoni and co-authors review a cell pathway as a possible target for new kidney cancer care, in a 2024 paper. Kidney cell cancer is the most common type of kidney cancer. It tends to act in an aggressive way, with spread to other sites and a poor outlook. Most cases are found by chance, often late, when spread has already begun.
Care is made harder by the fact that this cancer often resists both drug therapy and radiation. The pathway under review centers on a factor called Nrf2, which runs the cell's response to oxidative stress. Its level is raised in many tumors. The authors weigh signs that blocking or tuning this path could give new options for care and for judging risk.
Catalog record
| CREATOR | Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna, Georg C Hutterer |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |